BLUE KNIGHT: Ledger

Stories naming BLUE KNIGHT. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.

Investor	Rounds	Invested
No investors recorded yet. Know one?

Company	Kind	Announced	Price	Sources
BLUE KNIGHT is not recorded as having acquired anything.

2 deals

ENA Respiratory Receives US$5m Investment from Flu Lab to Support Clinical Development of Novel Intranasal Antiviral Host Defence Immune Enhancer, INNA-051

Melbourne pharmaceutical company ENA Respiratory has received US$5 million from California's Flu Lab to advance clinical testing of its nasal immune-boosting antiviral candidate INNA-051.

Brandon BioCatalyst portfolio 11 Feb 2025 BARDA BLUE KNIGHT Brandon Capital ENA Respiratory Johnson & Johnson Innovation The Minderoo Foundation Uniseed US COPD Foundation Flu Lab U.S. Department of Defense Christophe Demaison

Also Brandon Capital portfolio

BLUE KNIGHT

Funding history

Investors

What BLUE KNIGHT bought

People

Coverage

ENA Respiratory Receives US$5m Investment from Flu Lab to Support Clinical Development of Novel Intranasal Antiviral Host Defence Immune Enhancer, INNA-051